It's cheap, easy to make and in demand overseas. So why can't this Texas-born COVID-19 vaccine break into the U.S. market?

A Houston vaccine team would like a U.S. distributor but for now focuses its efforts abroad to inoculate those in countries where COVID-19 variants surface more quickly.

Related Keywords

New York ,United States ,Kenya ,India ,Sudan ,Texas ,Dominican Republic ,Brazil ,South Africa ,Colombia ,Houston ,Indonesia ,Peru ,Baylor College Of Medicine ,Ethiopia ,Americans ,America ,American ,Maria Bottazzi ,Peter Hotez ,Peter Attia ,Benjamin Neuman ,Maria Elena Bottazzi ,Justin Rex ,Robertj Kleberg Jr ,James Cutrell ,Sarah Everett ,Texasam University ,National Institutes Of Health ,World Health Organization ,National School Of Tropical Medicine ,Drug Administration ,Helenc Kleberg Foundation ,Pfizer ,Ut Southwestern Medical Center ,Texas Children Hospital Center ,Md Anderson Foundation ,Vaccine Development ,Johnson ,Baylor College ,Texas Children ,Hospital Center ,Texas Based Tito ,Handmade Vodka ,Biologicale Limited ,Warp Speed ,Tropical Medicine Lab ,National Institutes ,Saharan Africa ,Latin America ,National School ,Tropical Medicine ,